Xtant Medical (NYSEAMERICAN:XTNT) Stock Price Crosses Above Two Hundred Day Moving Average of $0.00

Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT)’s stock price crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.00 and traded as high as $0.88. Xtant Medical shares last traded at $0.84, with a volume of 74,084 shares trading hands.

Xtant Medical Trading Up 6.7 %

The company has a debt-to-equity ratio of 0.34, a current ratio of 2.82 and a quick ratio of 1.22.

Institutional Investors Weigh In On Xtant Medical

Several institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. purchased a new stake in Xtant Medical in the 3rd quarter worth approximately $805,000. AMH Equity Ltd purchased a new stake in Xtant Medical in the 3rd quarter worth approximately $653,000. Sterling Investment Advisors Ltd. purchased a new stake in Xtant Medical in the 3rd quarter worth approximately $38,000. AWM Investment Company Inc. bought a new position in shares of Xtant Medical in the 3rd quarter worth approximately $516,000. Finally, Goldman Sachs Group Inc. raised its position in shares of Xtant Medical by 156.7% in the 4th quarter. Goldman Sachs Group Inc. now owns 33,176 shares of the medical device company’s stock worth $37,000 after acquiring an additional 20,253 shares in the last quarter. 69.33% of the stock is currently owned by hedge funds and other institutional investors.

Xtant Medical Company Profile

Xtant Medical Holdings, Inc develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS DBM Putty for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; OsteoFactor, which contains various proteins and peptides that support bone formation and remodeling; OsteoWrap; and OsteoVive Plus, a growth factor enriched cellular bone matrix.